泰坦制药(TTNP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TTNP 泰坦制药

休市中 07-11 16:00:00 EDT

4.37

+0.02

+0.37%

最高4.55	最低4.07	成交量9,087
今开4.07	昨收4.35	日振幅11.03%
总市值399.13万	流通市值305.63万	总股本91.42万
成交额3.94万	换手率1.30%	流通股本70.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TTNP","market":"US","secType":"STK","nameCN":"泰坦制药","latestPrice":4.3659,"timestamp":1752264000000,"preClose":4.35,"halted":0,"volume":9087,"delay":0,"floatShares":700030,"shares":914200,"eps":-4.603773,"marketStatus":"休市中","change":0.0159,"latestTime":"07-11 16:00:00 EDT","open":4.07,"high":4.55,"low":4.07,"amount":39379.653101,"amplitude":0.110345,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.603773,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.35,"volumeRatio":1.6931877027192597,"impliedVol":2.0516,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/TTNP","defaultTab":"news","newsList":[{"id":"2550624962","title":"泰坦制药盘中异动 股价大涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550624962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550624962?lang=zh_cn&edition=full","pubTime":"2025-07-10 23:18","pubTimestamp":1752160733,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日23时18分，泰坦制药股票出现异动，股价大幅拉升5.57%。截至发稿，该股报4.55美元/股，成交量1367股，换手率0.10%，振幅8.12%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.86%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710231853a6a1e7e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710231853a6a1e7e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2546244247","title":"泰坦制药盘中异动 临近午盘快速上涨5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546244247","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546244247?lang=zh_cn&edition=full","pubTime":"2025-06-25 23:43","pubTimestamp":1750866180,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日23时43分，泰坦制药股票出现波动，股价快速上涨5.68%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.70%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625234301a4bd9c76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625234301a4bd9c76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2545488184","title":"泰坦制药盘中异动 股价大涨5.19%报4.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545488184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545488184?lang=zh_cn&edition=full","pubTime":"2025-06-23 22:07","pubTimestamp":1750687671,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日22时07分，泰坦制药股票出现异动，股价大幅拉升5.19%。截至发稿，该股报4.48美元/股，成交量1108股，换手率0.08%，振幅3.76%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.42%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062322075195282030&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062322075195282030&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2544602130","title":"泰坦制药盘中异动 下午盘快速跳水5.39%报4.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544602130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544602130?lang=zh_cn&edition=full","pubTime":"2025-06-17 01:29","pubTimestamp":1750094945,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日01时29分，泰坦制药股票出现异动，股价快速下挫5.39%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.50%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617012905a4ac8e24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617012905a4ac8e24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2542355073","title":"泰坦制药盘中异动跌5.50% 振幅达8.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542355073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542355073?lang=zh_cn&edition=full","pubTime":"2025-06-09 22:57","pubTimestamp":1749481057,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日22时57分，泰坦制药股票出现波动，股价大幅跳水5.50%。截至发稿，该股报4.39美元/股，成交量9.4699万股，换手率10.36%，振幅8.17%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.66%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092257379514eab0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092257379514eab0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2540506497","title":"泰坦制药盘中异动 大幅下跌5.16%报4.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540506497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540506497?lang=zh_cn&edition=full","pubTime":"2025-06-04 22:03","pubTimestamp":1749045789,"startTime":"0","endTime":"0","summary":"北京时间2025年06月04日22时03分，泰坦制药股票出现波动，股价急速下跌5.16%。截至发稿，该股报4.52美元/股，成交量1172股，换手率0.13%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.76%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604220309a6fa6146&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604220309a6fa6146&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2540979165","title":"泰坦制药盘中异动 股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540979165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540979165?lang=zh_cn&edition=full","pubTime":"2025-06-02 22:58","pubTimestamp":1748876330,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日22时58分，泰坦制药股票出现异动，股价快速上涨5.22%。截至发稿，该股报4.84美元/股，成交量1.8763万股，换手率2.05%，振幅4.13%。泰坦制药股票所在的生物技术行业中，整体涨幅为1.25%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602225850a6f73715&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602225850a6f73715&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2537130057","title":"泰坦制药盘中异动 早盘股价大跌5.01%报4.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537130057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537130057?lang=zh_cn&edition=full","pubTime":"2025-05-23 22:48","pubTimestamp":1748011735,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日22时48分，泰坦制药股票出现异动，股价快速下跌5.01%。截至发稿，该股报4.36美元/股，成交量1.1598万股，换手率1.27%，振幅7.95%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.02%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523224855a489d521&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523224855a489d521&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2537937041","title":"泰坦制药盘中异动 股价大跌5.20%报4.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537937041","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537937041?lang=zh_cn&edition=full","pubTime":"2025-05-22 00:07","pubTimestamp":1747843678,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日00时07分，泰坦制药股票出现异动，股价急速下跌5.20%。截至发稿，该股报4.12美元/股，成交量1.4085万股，换手率1.54%，振幅8.74%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.17%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522000758a48706e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522000758a48706e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2536687750","title":"泰坦制药盘中异动 早盘大幅拉升6.64%报4.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536687750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536687750?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:34","pubTimestamp":1747661651,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时34分，泰坦制药股票出现异动，股价急速上涨6.64%。截至发稿，该股报4.98美元/股，成交量2944股，换手率0.32%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.59%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213411975e64e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213411975e64e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2535821346","title":"泰坦制药盘中异动 早盘急速拉升5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535821346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535821346?lang=zh_cn&edition=full","pubTime":"2025-05-15 21:35","pubTimestamp":1747316150,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日21时35分，泰坦制药股票出现波动，股价大幅拉升5.71%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.20%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051521355094f7faeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051521355094f7faeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2534706275","title":"泰坦制药盘中异动 早盘快速上涨5.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534706275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534706275?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:39","pubTimestamp":1747057173,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时39分，泰坦制药股票出现异动，股价大幅上涨5.89%。截至发稿，该股报5.39美元/股，成交量8204股，换手率0.90%，振幅7.86%。泰坦制药股票所在的生物技术行业中，整体涨幅为2.81%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213933975745cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213933975745cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2534348055","title":"泰坦制药盘中异动 股价大涨6.32%报5.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534348055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534348055?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:46","pubTimestamp":1746798418,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时46分，泰坦制药股票出现波动，股价急速上涨6.32%。截至发稿，该股报5.63美元/股，成交量9966股，换手率1.09%，振幅6.60%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.43%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214658a47840b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214658a47840b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2533307591","title":"泰坦制药盘中异动 股价大涨6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533307591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533307591?lang=zh_cn&edition=full","pubTime":"2025-05-08 22:52","pubTimestamp":1746715944,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日22时52分，泰坦制药股票出现异动，股价快速拉升6.98%。截至发稿，该股报4.29美元/股，成交量4443股，换手率0.49%，振幅4.74%。泰坦制药股票所在的生物技术行业中，整体跌幅为3.27%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508225224a6d7d7c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508225224a6d7d7c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2533936669","title":"泰坦制药盘中异动 早盘快速拉升5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533936669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533936669?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:42","pubTimestamp":1746625358,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时42分，泰坦制药股票出现波动，股价快速上涨5.87%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.34%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507214238a6d66d33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507214238a6d66d33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2533650304","title":"泰坦制药盘中异动 大幅下跌6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533650304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533650304?lang=zh_cn&edition=full","pubTime":"2025-05-06 23:25","pubTimestamp":1746545135,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日23时25分，泰坦制药股票出现异动，股价大幅下跌6.25%。截至发稿，该股报3.60美元/股，成交量1307股，换手率0.14%，振幅2.34%。泰坦制药股票所在的生物技术行业中，整体跌幅为4.19%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506232535aa2c84a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506232535aa2c84a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2532826262","title":"泰坦制药盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532826262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532826262?lang=zh_cn&edition=full","pubTime":"2025-05-02 23:43","pubTimestamp":1746200603,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日23时43分，泰坦制药股票出现波动，股价大幅跳水5.01%。截至发稿，该股报3.66美元/股，成交量2437股，换手率0.27%，振幅3.60%。泰坦制药股票所在的生物技术行业中，整体涨幅为1.22%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502234323a6d1330e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502234323a6d1330e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2530115605","title":"泰坦制药盘中异动 早盘股价大涨8.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530115605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530115605?lang=zh_cn&edition=full","pubTime":"2025-04-25 23:25","pubTimestamp":1745594733,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日23时25分，泰坦制药股票出现异动，股价快速上涨8.44%。截至发稿，该股报4.11美元/股，成交量983股，换手率0.11%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.21%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042523253397453124&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042523253397453124&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2517169084","title":"泰坦制药盘中异动 股价大跌5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517169084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517169084?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:38","pubTimestamp":1741271907,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时38分，泰坦制药股票出现异动，股价急速下挫5.54%。截至发稿，该股报3.75美元/股，成交量7577股，换手率0.83%，振幅8.19%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.53%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223827a2629246&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223827a2629246&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2516677528","title":"泰坦制药盘中异动 早盘大幅上涨8.21%报4.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677528","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677528?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:48","pubTimestamp":1741099709,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时48分，泰坦制药股票出现异动，股价急速上涨8.21%。截至发稿，该股报4.35美元/股，成交量2124股，换手率0.23%，振幅1.99%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.56%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224830a25f0a40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224830a25f0a40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.titanpharm.com","stockEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":-0.0426},{"period":"3month","weight":0.1896},{"period":"6month","weight":0.3072},{"period":"1year","weight":-0.109},{"period":"ytd","weight":0.3392}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Titan Pharmaceuticals, Inc.于1992年2月根据特拉华州法律成立。该公司是一家制药公司。该公司专注于利用专有的长期给药平台ProNeura开发治疗药物，用于治疗特定的慢性疾病，其中稳态给药有可能提供疗效。ProNeura由一种由乙烯-醋酸乙烯酯（“EVA”）和一种药物混合物制成的小型固体植入物组成。产生的产物是一种固体基质，设计用于在简短的门诊程序中进行皮下给药，并在治疗期结束时以类似方式移除。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.010618},{"month":2,"riseRate":0.6,"avgChangeRate":0.057895},{"month":3,"riseRate":0.3,"avgChangeRate":-0.031972},{"month":4,"riseRate":0.3,"avgChangeRate":-0.043803},{"month":5,"riseRate":0.4,"avgChangeRate":-0.047799},{"month":6,"riseRate":0.5,"avgChangeRate":-0.001038},{"month":7,"riseRate":0.3,"avgChangeRate":0.081919},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.134895},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.189655},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.05513},{"month":11,"riseRate":0.3,"avgChangeRate":-0.064476},{"month":12,"riseRate":0.2,"avgChangeRate":-0.096803}],"exchange":"NASDAQ","name":"泰坦制药","nameEN":"Titan Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰坦制药(TTNP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰坦制药(TTNP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰坦制药,TTNP,泰坦制药股票,泰坦制药股票老虎,泰坦制药股票老虎国际,泰坦制药行情,泰坦制药股票行情,泰坦制药股价,泰坦制药股市,泰坦制药股票价格,泰坦制药股票交易,泰坦制药股票购买,泰坦制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰坦制药(TTNP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰坦制药(TTNP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}